Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry.
Martina KojanovaMilena TanczosovaDaniela StrosovaPetra CetkovskaJorga FialovaTomas DolezalAlena MachovcovaSpyridon Gkalpakiotisnull nullPublished in: The Journal of dermatological treatment (2022)
This real-life study confirmed the effectiveness and safety of dupilumab in a real-life setting during the COVID-19 pandemic. Our study revealed a higher frequency of infections and a lower conjunctivitis frequency than other real-life studies and clinical trials.